We are live on ! Find out more
MDVX

Medovex Corp. Common Stock
MDVX

Delisted

MDVX was delisted on the 15th of November, 2017.

6 hedge funds and large institutions have $82K invested in Medovex Corp. Common Stock in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

5% less capital invested

Capital invested by funds: $86K → $82K (-$4K)

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$51K +$70.3K +45,210 +3,694%
Citadel Advisors
2
Citadel Advisors
Florida
$16K +$22.8K +14,655 New
MHS
3
M Holdings Securities
Oregon
$13K
BFA
4
BlackRock Fund Advisors
California
$2K +$3.14K +2,020 New
Millennium Management
5
Millennium Management
New York
-$51K -21,553 Closed
TRCT
6
Tower Research Capital (TRC)
New York
-$1.27K -819 Closed
Morgan Stanley
7
Morgan Stanley
New York
+$30 +19 New

MDVX Hedge Fund Activity: Q4 2015 in Review

6 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q4 2015, worth a combined $82K — down 4.7% from $86K a quarter earlier.

Fund positioning in MDVX was balanced in Q4 2015: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $70.3K. The largest seller was Millennium Management, exiting entirely with an estimated $51K sold.

  • 6 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $82K of Medovex Corp. Common Stock stock for Q4 2015, down 4.7% quarter-over-quarter.
  • 3 funds opened new Medovex Corp. Common Stock positions in Q4 2015 and 3 closed out, a net change of 0 holders.
  • The largest Medovex Corp. Common Stock buyer in Q4 2015 was UBS Group, an estimated $70.3K added.
  • The largest Medovex Corp. Common Stock seller in Q4 2015 was Millennium Management, an estimated $51K sold.

Based on aggregated 13F filings for Q4 2015.